MAS1L and Parkinson disease: However, it is not known whether the dysregulation of the agonistic [22,23] AT2 and Mas receptor autoantibodies (AT2-AAs, MasR-AAs) and the correlations among different RAS autoantibodies occur in PD patients as compared with non-PD controls.